Skip to main content
SpringerLink
Log in

Lipid-lowering therapy still underused in high-risk groups

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lipid-lowering therapy still underused in high-risk groups. Pharmacoecon. Outcomes News 306, 5 (2001). https://doi.org/10.1007/BF03269259

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03269259

Keywords

Search

Navigation